UPC Analytics
DEEN
Übersicht · Eingereicht: 12. Dez. 2024

UPC_APP_65673/2024

FLUID DELIVERY DEVICE WITH TRANSCUTANEOUS ACCESS TOOL, INSERTION MECHANISM AND BLOOD GLUCOSE MONITORING FOR USE THEREWITH

Prozessuale & UnteranträgeKostenfestsetzungenMilan CDGenericCase Closed
ÜbersichtEntscheidungenDokumenteZeitverlauf
Parteien

Kläger

  • EOFLOW Co., Ltd.
Vertreter: Marc Grunwald (Peterreins Schley)

Beklagte

  • Insulet Corporation
Vertreter: Ronald Mirko Weinert
Richter
  • Andrea Postiglione
  • Anna-Lena Klein
  • Uwe Schwengelbeck
Patente
  • EP4201327
  • EP 4 201 327
CPC-Codes: A61M5/1723, A61M5/1452, A61M5/158, A61B5/14865, A61M5/14244, F04B9/02, A61B5/14532, A61M2230/201, A61M2005/14506, A61M5/14248, B65D83/761, A61M5/3291…

Sektor: Packaging & Conveying

Ausgang
Nur Kosten
Eingereicht: 12. Dez. 2024
Erste Entscheidung: 15. Feb. 2025
Sprache: English

Procedural order by Milan Central Division (UPC_CFI_380/2024, 15 February 2025) on EOFLOW's application for costs following the rejection of Insulet's preliminary injunction. The court held that costs of PI proceedings must be settled with the final decision on the merits and cannot be parcelled out according to the outcome of individual stages while merits proceedings are ongoing or to follow.

Im UPC-Register öffnen